Header Logo

Connection

FREDERICK LANG to Glioblastoma

Back to Details
This is a "connection" page, showing publications FREDERICK LANG has written about Glioblastoma.
FREDERICK LANG
Connection Strength
6.382
Glioblastoma
  1. Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro Oncol. 2024 02 02; 26(2):236-250.
    View in: PubMed
    Score: 0.443
  2. Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics. Neuro Oncol. 2024 01 05; 26(1):127-136.
    View in: PubMed
    Score: 0.441
  3. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2022 Mar 01; 136(3):757-767.
    View in: PubMed
    Score: 0.374
  4. Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. Neurosurg Focus. 2021 02; 50(2):E6.
    View in: PubMed
    Score: 0.360
  5. Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors. Neurosurg Clin N Am. 2021 Jan; 32(1):93-104.
    View in: PubMed
    Score: 0.354
  6. Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. Childs Nerv Syst. 2013 Jan; 29(1):55-64.
    View in: PubMed
    Score: 0.204
  7. Glioblastoma resection. J Neurosurg. 2012 May; 116(5):1166-7; author reply 1167-8.
    View in: PubMed
    Score: 0.194
  8. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009 Dec 01; 69(23):8932-40.
    View in: PubMed
    Score: 0.166
  9. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005 Apr 15; 65(8):3307-18.
    View in: PubMed
    Score: 0.120
  10. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.
    View in: PubMed
    Score: 0.111
  11. Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma. J Neurosci. 2023 11 22; 43(47):8043-8057.
    View in: PubMed
    Score: 0.109
  12. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nat Cancer. 2023 Oct; 4(10):1455-1473.
    View in: PubMed
    Score: 0.108
  13. Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. Sci Adv. 2023 08 04; 9(31):eadf3984.
    View in: PubMed
    Score: 0.107
  14. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med. 2023 Jun; 29(6):1370-1378.
    View in: PubMed
    Score: 0.105
  15. Current surgical management of glioblastoma. Cancer J. 2003 Mar-Apr; 9(2):113-25.
    View in: PubMed
    Score: 0.104
  16. Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. Clin Cancer Res. 2022 05 02; 28(9):1979-1990.
    View in: PubMed
    Score: 0.098
  17. A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-8.
    View in: PubMed
    Score: 0.098
  18. HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion. Mol Ther. 2022 04 06; 30(4):1610-1627.
    View in: PubMed
    Score: 0.097
  19. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors. J Neurointerv Surg. 2022 Jun; 14(6):533-538.
    View in: PubMed
    Score: 0.095
  20. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 10 01; 10(10).
    View in: PubMed
    Score: 0.094
  21. Targeting the av integrin/TGF-? axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest. 2021 07 15; 131(14).
    View in: PubMed
    Score: 0.093
  22. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer Discov. 2021 11; 11(11):2904-2923.
    View in: PubMed
    Score: 0.092
  23. Intraarterial delivery of virotherapy for glioblastoma. Neurosurg Focus. 2021 02; 50(2):E7.
    View in: PubMed
    Score: 0.090
  24. Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment. Oncogene. 2020 12; 39(50):7253-7264.
    View in: PubMed
    Score: 0.088
  25. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577.
    View in: PubMed
    Score: 0.085
  26. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
    View in: PubMed
    Score: 0.085
  27. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Discov. 2020 03; 10(3):371-381.
    View in: PubMed
    Score: 0.084
  28. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. 2020 01 01; 86(1):112-121.
    View in: PubMed
    Score: 0.083
  29. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 06 10; 21(6):775-785.
    View in: PubMed
    Score: 0.080
  30. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455.
    View in: PubMed
    Score: 0.077
  31. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299.
    View in: PubMed
    Score: 0.076
  32. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol. 2017 Oct 19; 19(11):1494-1502.
    View in: PubMed
    Score: 0.072
  33. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy. 2017 04; 19(4):445-457.
    View in: PubMed
    Score: 0.068
  34. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol. 2017 Jan; 29(1):46-58.
    View in: PubMed
    Score: 0.068
  35. The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma. Mol Cancer Res. 2016 12; 14(12):1277-1287.
    View in: PubMed
    Score: 0.067
  36. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51. Neuro Oncol. 2016 08; 18(8):1109-19.
    View in: PubMed
    Score: 0.064
  37. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112.
    View in: PubMed
    Score: 0.063
  38. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97.
    View in: PubMed
    Score: 0.062
  39. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells. Cancer Res. 2015 Jun 01; 75(11):2337-48.
    View in: PubMed
    Score: 0.060
  40. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol. 2015 Nov; 17(11):1463-73.
    View in: PubMed
    Score: 0.060
  41. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8).
    View in: PubMed
    Score: 0.057
  42. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628.
    View in: PubMed
    Score: 0.056
  43. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol. 2014 Mar 10; 32(8):774-82.
    View in: PubMed
    Score: 0.055
  44. Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma. Cancer Cell. 2013 Sep 09; 24(3):331-46.
    View in: PubMed
    Score: 0.054
  45. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26.
    View in: PubMed
    Score: 0.053
  46. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65.
    View in: PubMed
    Score: 0.051
  47. av?8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell. 2013 Feb; 24(4):474-82.
    View in: PubMed
    Score: 0.051
  48. REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells. 2012 Mar; 30(3):405-14.
    View in: PubMed
    Score: 0.048
  49. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. J Neurooncol. 2012 May; 107(3):487-501.
    View in: PubMed
    Score: 0.048
  50. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by ?8 integrin. Cancer Res. 2011 Oct 15; 71(20):6371-81.
    View in: PubMed
    Score: 0.047
  51. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73.
    View in: PubMed
    Score: 0.045
  52. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg. 2011 Mar; 114(3):576-84.
    View in: PubMed
    Score: 0.043
  53. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. J Proteome Res. 2010 May 07; 9(5):2098-108.
    View in: PubMed
    Score: 0.043
  54. Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res. 2010 Jan 15; 16(2):461-73.
    View in: PubMed
    Score: 0.042
  55. Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther. 2010 Jan; 9(1):67-78.
    View in: PubMed
    Score: 0.042
  56. Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J Proteome Res. 2010 Jan; 9(1):430-43.
    View in: PubMed
    Score: 0.042
  57. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res. 2009 Apr; 7(4):489-97.
    View in: PubMed
    Score: 0.040
  58. Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor. Int J Oncol. 2008 Jul; 33(1):5-15.
    View in: PubMed
    Score: 0.038
  59. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
    View in: PubMed
    Score: 0.036
  60. Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. J Proteome Res. 2007 Feb; 6(2):869-75.
    View in: PubMed
    Score: 0.034
  61. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 2006 Apr 01; 66(7):3593-602.
    View in: PubMed
    Score: 0.032
  62. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res. 2006 Jan 15; 12(2):556-62.
    View in: PubMed
    Score: 0.032
  63. PAX6 suppresses growth of human glioblastoma cells. J Neurooncol. 2005 Feb; 71(3):223-9.
    View in: PubMed
    Score: 0.030
  64. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7.
    View in: PubMed
    Score: 0.028
  65. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities. Nat Commun. 2020 06 10; 11(1):2935.
    View in: PubMed
    Score: 0.022
  66. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Oncotarget. 2016 May 24; 7(21):30626-41.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.